ABSTRACT Common dietary supplemental methionine (Met) sources include DL-methionine (DL-Met) and the Met precursor DL-2-hydroxy-4-(methylthio) butanoic acid (DL-HMTBA). For bio-utilization, D-Met and DL-HMTBA are converted into L-Met through oxidation and transamination. The objective of this study was to determine the effect of different dietary supplemental Met sources on gene expression and enzyme activity of Met oxidases in male broiler chickens. Liver, muscle, duodenum, jejunum, and ileum were collected at days 10 (d 10), 21 (d 21), and 26 (d 26) post-hatch from male broiler chickens that were fed a basal diet deficient in sulfur amino acids (SAA) (control), or the control diet supplemented with DL-Met, L-Met, or DL-HMTBA to meet SAA requirements. The mRNA abundance of D-Met oxidase, L-HMTBA oxidase, and D-HMTBA oxidase was measured by realtime PCR, and oxidase activities were measured using colorimetric assays (n = 5). Liver expressed more Dand L-HMTBA oxidase mRNA, while breast muscle and liver expressed more D-Met oxidase mRNA than other tissues. In the liver, DL-HMTBA and L-Met supplementation were associated with greater mRNA abundance of L-HMTBA oxidase compared to the control diet-fed group at d 10 but not d 21 or d 26. DL-HMTBA supplementation, however, was not associated with changes in the mRNA abundance of D-HMTBA oxidase. The Met-deficient diet at d 26 was associated with greater hepatic abundance of DAO mRNA, which is responsible for oxidation of amino acids. Oxidase activities were similar among the Met deficient and Metsupplemented groups. In conclusion, dietary Met supplementation influenced the transcriptional regulation and activity of Met oxidases in a tissue and age-specific manner. Met oxidases may thus act as a determining factor in the bioefficacy of different dietary supplemental Met sources.
INTRODUCTION
In poultry diets, methionine (Met) is typically the first limiting amino acid. Met is a precursor for the synthesis of proteins and serves as the predominant amino acid for translation initiation. In addition, Met participates in methyl group metabolism and is an intermediate in the biosynthesis of other important molecules such as cysteine, glutathione, and taurine. Met deficiency results in reduced protein accretion and growth rate as well as impaired immune competence (Zhang and Guo, 2008) .
To overcome this dietary limitation, supplemental Met sources are provided in the feed. Two common sources are DL-methionine (DL-Met) in the peroxisomal and mitochondrial fractions from chicken liver and kidney (Scott et al., 1969) . In rat liver, KMB is transaminated by the enzyme transaminase using glutamine or asparagine as amino donors to produce L-Met (Backlund et al., 1982) . In contrast, in chicken liver, leucine, isoleucine, and valine act as amino donors for Met synthesis while glutamine is much less effective (Gordon and Sizer, 1965) . Transaminase is ubiquitous and is not thought to be a limiting step in the transformation process, although this has not been definitively demonstrated.
D-HMTBA and L-HMTBA are oxidized to KMB using two different enzymatic systems, which are located in two different cellular organelles (Dibner and Knight, 1984) . D-2-hydroxy acid dehydrogenase (D-HADH; EC 1.1.99.6) is encoded by the LDHD gene and is located in the mitochondria in various tissues. D-HADH catalyzes the conversion of D-HMTBA to KMB, using NAD and NADP as cofactors. L-2-hydroxy acid oxidase (L-HAOX; EC 1.1.3.15) catalyzes the conversion of L-HMTBA to KMB and is mainly located in the hepatic and renal peroxisomes of chickens and rats. FAD and flavin mononucleotide are cofactors for L-HAOX. There are two isoforms of L-HAOX, HAO1, and HAO2. HAO1, which is encoded by the HAO1 gene, is believed to be involved mainly in L-HMTBA oxidation since it preferentially oxidizes short-chain aliphatic 2-hydroxyacids (Ferjancic-Biagini et al., 1998) . Hydrogen peroxide is the common byproduct for both oxidase reactions. In both cases the resulting KMB is transaminated to L-Met by transaminase. Conversion of DL-HMTBA to Met takes place principally in the liver, but also occurs in the small intestine (Martin-Venegas et al., 2006a,b; 2011) .
Many studies have addressed the relative bioavailability of different dietary supplemental Met sources in broiler chickens, with different conclusions. Depending upon the production parameter measured (e.g., weight gain, feed conversion ratio, breast meat yield), the bioefficacy of DL-HMTBA compared to DL-Met ranges from ∼ 65% to 88% on a product weight to weight basis (e.g., Lemme et al., 2002; Hoehler et al. 2005; Elwert et al. 2008 , Agostini et al., 2016 and meta-analyzed in Vazquez-Anon et al., 2006; Sauer et al., 2008) . The calculation of bioefficacy is complicated (Aggrey et al., 2017) . For example, Met + Cys content of a basal diet and incremental levels of DLM and DL-HMTBA can lead to the absence of a data point appearing in the first linear phase of the regression line and result in a lack of sensitivity for a correct estimation of bioavailability. Following the guidelines of Littell et al. (1997) , DL-HMTBA has a lower bioefficacy than DL-Met on an equimolar basis (Sauer et al., 2008) . The underlying mechanism for this difference in bioavailability has not been fully elucidated. DL-HMTBA is excreted at around 15 to 20% of its intake (Saunderson, 1985) . DL-HMTBA contains dimers and oligomers, which are not absorbed or are absorbed but not utilized and therefore excreted (Mitchell and Lemme, 2008; Maenz and Engele-Schaan, 1996) . The objective of this study was to determine the effect of different dietary supplemental Met sources (L-Met, DL-Met, and DL-HMTBA) on gene expression and enzymatic activity of Met oxidases in male broiler chickens.
MATERIALS AND METHODS

Animals, Diets, and Tissue Collection
Male Cobb 500 broiler chickens were obtained locally on day of hatch, randomly distributed into pens (6 replicate pens/treatment; ∼10 chicks per pen) and given one of four experimental diets: Control (C): diet deficient in methionine plus cysteine (Met + Cys), without any supplementation of Met sources; DL-Met: control diet + 0.22% DL-Met; L-Met: control diet + 0.22% L-Met and DL-HMTBA: control diet + 0.31% DL-HMTBA (to provide 0.22% DL-Met equivalent). The supplementation calculated for L-Met was recalculated for DL-Met and DL-HMTBA considering 100 and 65% bioefficacy, respectively, which resulted in amounts of 0.22% for DL-Met or L-Met and 0.31% for DL-HMTBA. DL-HMTBA consists of 88% pure substance, which includes 23% oligomers of DL-HMTBA (MartinVenegas et al., 2006a,b) . Furthermore, the 65% bioefficacy level for DL-HMTBA was chosen to be similar to previous reports (Lemme et al., 2002; Hoehler et al., 2005; Elwert et al., 2008) and to ensure that the chickens were growing at equal rates and thus were analyzed at equivalent body weights.
Chickens were given ad libitum access to feed and water. A starter diet was fed from day 0 (d 0) to d 10, a grower diet from d 11 to d 21, and a finisher diet from d 22 to d 26. Feed was produced by Research Diet Services BV (Utrecht, Netherlands). Basal diets were formulated to meet the broilers' requirements (Aminochick 2.0, Evonik Nutrition & Care GmbH, Germany) except for Met + Cys. The three Met sources DL-Met (Evonik), L-Met (Evonik-Rexim), and DL-HMTBA (Novus) were added as supplements to the basal diets in order to meet or exceed the Met + Cys requirements for broilers (Table 1) .
Growth performance data including individual body weight, feed intake, feed conversion efficiency (feed intake/body weight gain) and relative organ weight (organ weight/body weight) were recorded at the end of each diet phase (d 10, 21, 26) .
At d 10, 21, and 26, 5 birds per treatment were euthanized by cervical dislocation and liver, breast muscle, and intestine were collected. The intestine was separated into duodenum, jejunum, and ileum. Digesta were gently squeezed out of the intestine and segments were rinsed three times in phosphate-buffered saline (NaH 2 PO 4 1.47 mmol/L, Na 2 HPO 4 8.09 mmol/L, NaCl 145 mmol/L). Intestinal segments were stored in RNAlater (Life Technologies, Carlsbad, CA) at −80
• C. Liver and breast muscle samples were snap-frozen in liquid nitrogen and then stored at −80
• C. All animal protocols were approved by the Institutional Animal Care and Use Committee at Virginia Tech.
Gene Expression of Met Oxidases
Each tissue sample was homogenized in Tri-Reagent (Molecular Research Center, Cincinnati, OH) using 5 mm stainless steel beads (Qiagen, Valencia, CA) and a Tissue Lyser II (Qiagen) at 25 Hz for 2 min (n = 5). The Direct-zol RNA MiniPrep Kit and DNase I (Zymo Research, Irvine, CA) were used for total RNA isolation and purification following the manufacturer's instructions. The total RNA samples were evaluated for quality by agarose-formaldehyde gel electrophoresis and concentration and purity assessed by spectrophotometry at 260/280/230 nm with a NanoDrop 1000 (Thermo Scientific, Waltham, MA).
First-strand cDNA was synthesized from 500 ng total RNA with a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Grand Island, NY). Reactions were performed under the following conditions: 25
• C for 10 min, 37
• C for 120 min, and 85
• C for 5 min. Expression of DAO, HAO1, LDHD, and six reference genes, β-actin, hexose-6-phosphate dehydrogenase (H6PD), lactate dehydrogenase A (LDHA), ribosomal protein L4 (PRL4), ribosomal protein large, P0 (PRLP0), and ribosomal protein large, P1 (PRLP1) were assayed using real time PCR and the relative quantification method (Hellemans et al., 2007) . Primers designed for real time PCR are listed in Table 2 and were validated for amplification efficiency before use (90 to 115% efficiency). Real-time PCR was performed in duplicate in 10 μL volume reactions that contained 5 μL Fast SYBR Green Master Mix (Applied Biosystems), 0.5 μL each of 5 μM forward and reverse primers, and 3 μL of 10-fold diluted cDNA using a 7500 Fast Real-Time PCR System (Applied Biosystems). PCR was performed under the following conditions: 95
• C for 20 s and 40 cycles of 90
• C for 3 s plus 60
• C for 30 s. A dissociation step consisting of 95
• C for 15 s, 60
• C for 1 min, 95
• C for 15 s and 60
• C for 15 s was performed at the end of each PCR reaction to verify that a single amplicon was generated.
Stability of reference genes was tested using geNorm. Three reference genes (PRL4, PRLP0, and PRLP1) that showed the highest stability were selected from the panel of six reference genes (Vandesompele et al., 2002) . The Cq values of each target gene were analyzed using algorithms provided by Hellemans et al. (2007) . Briefly, the average Cq value was calculated for PCR replicates, then transformed into relative quantities (RQ) using (1+e) −ΔCq , where ΔCq = Cq (target sample) -Cq (average). The normalization factor (NF) for each sample was calculated based on the geometric mean of RQ of the three reference genes for that sample. The normalized relative quantity (NRQ) equals RQ/NF (sample specific), which was used for statistical analysis.
Preparation of Cell Extracts and Enzymatic Assays for Met Oxidases
The preparation of cell extracts followed the procedures of Dibner and Knight (1984) . Approximately 0.1 g of each tissue sample was homogenized in 1 mL of homogenizing buffer using 5 mm stainless steel beads and a Tissue Lyser II (n = 5). The homogenizing buffer consisted of 0.25 M sucrose, 1 mM phenyl methylsulfonyl fluoride, and 0.02 M potassium phosphate, pH 7.5. Mitochondrial and peroxisomal fractions were prepared The vitamin-mineral premix supplied the following per kilogram of diet: 12,000 IU vitamin A (retinyl acetate), 2,400 IU vitamin D 3 (cholecalciferol), 50 mg vitamin E (DL-α-tocopherol), 1.5 mg vitamin K 3 (menadione), 2.0 mg vitamin B 1 (thiamine), 7.5 mg vitamin B 2 (riboflavin), 3.5 mg vitamin B 6 (pyridoxine-HCl), 20 μg vitamin B 12 (cyanocobalamin), 35 mg niacin, 10 mg D-pantothenic acid, 460 mg choline chloride, 1.0 mg folic acid, 0.2 mg biotin, 267 mg ferrous sulfate, 48 mg copper sulfate, 142 mg manganese oxide, 169 mg zinc sulfate, 1.1 mg potassium iodide, 0.33 mg sodium selenite.
2 DM: dry matter; CP: crude protein; MET: methionine; CYS: cysteine; M+C: methionine + cysteine, the values in brackets also considering DL-2-hydroxy-4-(methylthio) butanoic acid content; LYS: lysine; THR: threonine; TRP: tryptophan; ARG: arginine; ILE: isoleucine; LEU: leucine; VAL: valine; HIS: histidine; PHE: phenylalanine; TYR: tyrosine; GLY: glycine; SER: serine; PRO: proline; ALA: alanine; ASP: aspartate; GLU: glutamate.
3 Numbers in brackets show results of a calculation to transform DL-HMTBA content to the equivalent Met+Cys content by multiplying the DL-HMTBA content by 0.65 (bioavailability of DL-HMTBA).
by differential centrifugation. Tissue homogenates were centrifuged at 350 × g for 10 min to remove cells and cell debris. The supernatant was centrifuged at 3,000 × g for 15 min to enrich for mitochondria in the pellet, which was subsequently resuspended and washed twice in 0.01 M Tris, pH 6.8. The supernatant from the 3,000 × g step was centrifuged at 22,000 × g for 15 min to yield a peroxisome enriched pellet. The peroxisome pellet was resuspended and washed twice in 0.01 M Tris, pH 7.5. The protein concentration in both fractions was measured using the Bradford assay (Sigma-Aldrich, St. Louis, MO).
The activity of the three oxidases was measured as described by Dibner and Knight (1984) . L-HAOX activity was measured in the peroxisome fraction. 0.1 mL (approximately 0.2 mg protein) of peroxisome fraction was added to a reaction buffer containing 0.75 mL 0.01 M Tris, pH 7.5, 2.5 μmol L-HMTBA, 0.25 μmol Enzyme reactions were stopped by adding 0.75 mL of cold 10% trichloroacetic acid and were incubated on ice for 10 min. The produced KMB was detected using a spectrophotometric assay. Briefly, the enzyme reactions were centrifuged at 12,000 × g for 3 min. A 200 μL aliquot of supernatant was transferred to a microfuge tube, and 60 μL of 0.25% dinitrophenylhydrazine in 2 N HCl was added. After a 10 min incubation at room temperature, 140 μL of 4 N NaOH were added. A 200 μL aliquot of reaction solution was transferred to one well of the 96 well plate in duplicate and the keto acid KMB was quantified colorimetrically at 435 nm with a multi-mode plate reader (Infinite M200 Pro, Tecan, Morrisville, NC). One unit of enzyme activity was defined as the amount yielding 1 μg of KMB per milligram of protein under standard reaction conditions.
The procedure for the synthesis of D-and L-HMTBA was adapted from previous reports (Deechongkit et al., 2004; Feifel et al., 2007) . D-and L-Met were purchased from Acros Organics (Pittsburgh, PA). The amino acids (2.00 g, 13.4 mmol) were individually weighed into 250 mL round-bottom flasks and dissolved in 4:1 deionized water: acetic acid (v/v 50 mL). Each flask was fitted with a pressure-equalizing dropping funnel and cooled to 0
• C using an ice-bath. Sodium nitrite (1.85 g, 26.8 mmol; Sigma-Aldrich) was dissolved in 15 mL of deionized water and placed in the dropping funnel. The sodium nitrite solution was added dropwise to the flask over a period of 15 min after which the ice bath was removed and the reaction mixture was warmed to room temperature and stirred overnight. The reaction mixture was transferred to a separatory funnel and extracted three times with approximately 50 mL of ethyl acetate (Fisher Scientific, Pittsburgh, PA). The organic extracts were combined, dried using Na 2 SO 4 and concentrated using rotary evaporation. The crude material was purified using column chromatography (9:1 chloroform: methanol; Fisher Scientific) to obtain the desired product as a yellow oil. Flash column chromatography was completed using silica gel (230 to 400 mesh) from Silicycle Inc (Quebec City, Quebec, Canada).
1 H NMR spectra for the hydroxyl acids were recorded on a Bruker Avance 300 MHz spectrometer and referenced to residual protio solvents. Yield of L-2-hydroxy-4-(methylthio)butanoic acid was 0.210 g (10%) and yield of D-2-hydroxy-4-(methylthio)butanoic acid was 0.157 g (8%). Both compounds showed greater than 90% purity.
Statistical Analysis
All data were checked for normality and homogeneity of variances. For both the gene expression and enzyme activity data, the overall tissue and age main effects were analyzed within each target gene (enzyme) using one-way ANOVA. Means were separated using Tukey's HSD Test. To test the effect of treatment, two statistical models were employed: 1) the main effects of treatment and age and the treatment by age interaction, within each tissue (liver, breast muscle, duodenum, jejunum, and ileum) and 2) the main effects of treatment and tissue and the treatment by tissue interaction, within each age (d 10, d 21 and d 26). Data from model 1 were analyzed by two-way ANOVA. A split-plot design was considered when analyzing data from model 2, with chicks as the whole plot, the tissue as the split plot and chicks as the random effect. Contrasts were used to separate treatment means. JMP Pro version 12.0 (SAS Institute, Cary, NC) was used for the statistical analysis. Data are presented as least squares means ± SEM and statistical significance was assigned at P < 0.05.
RESULTS
Growth Performance
Growth performance data were reported previously by Zhang et al. (2017) and are summarized in Table 3 . Met supplementation (DL-Met, L-Met, DL-HMTBA) improved body weight gain and relative breast muscle weight at d 10, d 21, and d 26 and feed conversion from d 10 to d 26 compared to the control. There were no differences between the three supplementary Met sources considering bioefficacy of 100% for L-Met and 65% for DL-HMTBA compared to DL-Met.
Gene Expression of Met Oxidases
For the different tissues, abundance of HAO1 and LDHD mRNA was greater in liver than breast muscle and small intestine, while abundance of DAO mRNA was greatest in breast muscle, intermediate in liver, and lowest in the small intestine (Figure 2) .
Gene expression data were analyzed using two statistical models, as described in Materials and Methods. For model 1, which analyzed gene expression within each tissue, there was a main effect of treatment for DAO and HAO1 mRNA in the liver (Table 4 ). Control (Met-deficient) chickens had greater hepatic DAO mRNA than DL-Met, L-Met and DL-HMTBA-supplemented chickens and chickens fed DL-Met had less hepatic HAO1 mRNA than L-Met and DL-HMTBA-fed chickens. For each gene, there were main effects of age in different tissues (Table 4) For model 2, which analyzed gene expression within different days, there were treatment by tissue interactions for DAO and HAO1 mRNA (Table 5) . At d 10 in the liver, HAO1 mRNA was greater in the DL-HMTBA group than control and DL-Met groups. In addition, HAO1 mRNA was greater in the L-Met group compared to control and DL-Met groups ( Figure 3A) . At d 26, DAO mRNA was greater in the control than other three groups in liver and breast muscle and was greater (Table 5 ).
Enzymatic Activity of Met Oxidases
L-HAOX activity was lower in the ileum than other tissues. D-HADH activity was greater in the jejunum than duodenum, liver and breast muscle, and greater in the ileum than the liver. D-AAOX activity was greater in the duodenum, liver and breast muscle than the jejunum, and greater in the liver than the ileum (Figure 4) .
The enzyme activities, similar to mRNA relative quantity values, were analyzed using the two different models. For model 1, there were no main effects of treatment; however, there were main effects of age (Table 6) (Table 7) . D-AAOX activity was greater in the duodenum and breast muscle than jejunum at d 21 and greater in the liver than jejunum and ileum at d 26. Control chickens had greater L-HAOX activity 
DISCUSSION
This study examined the mRNA abundance and activities of the three oxidases that convert D-Met, D-HMTBA, and L-HMTBA into KMB as a first step in their conversion to L-Met in different tissues of chickens, following consumption of a Met-deficient diet or diets supplemented with L-Met, DL-Met, or DL-HMTBA. LDHD, HAO1, and DAO mRNA were expressed in the liver, muscle, and small intestine, consistent with previous reports (Dibner and Knight, 1984; Brachet and Puigserver, 1992; Martin-Venegas et al., 2006a,b) .
Met supplementation affected gene expression. DL-HMTBA and L-Met fed chickens expressed more hepatic HAO1 mRNA than the DL-Met group at d 10. The DL-HMTBA result was expected, because the HAO1 gene encodes L-HAOX, which converts L-HMTBA to KMB. A similar effect, however, was missing at d 21 and d 26. Martin-Venegas et al. (2011) reported a similar upregulation of L-HAOX activity in Caco-2 cells grown in media supplemented with DL-HMTBA, but this had no effect on Met production compared to the control. Ferjancic-Biagini et al. (1998) reported that L-HAOX has an oxidative decarboxylation activity in vitro, with NADH as a cofactor. Thus, L-HAOX may play a broader role in catalyzing the conversion of more substrates than expected. Chickens fed the control Met deficient diet expressed more hepatic DAO mRNA than Met supplemented groups at d 26. This result indicates that Met deficiency caused an upregulation of DAO mRNA, which may be a mechanism for promoting the conversion of any D-amino acid into the L form necessary for protein synthesis. This may also promote oxidation of D-amino acids in a condition where there is an excess of amino acids due to Met deficiency, since Met is the first limiting amino acid in broiler diets. However, in a majority of important tissues like muscle and different segments of intestine, there was no effect of Met source on DAO mRNA. It is also not clear why this effect exclusively occurred at d 26.
There was no effect of Met deficiency or dietary Met source on LDHD mRNA abundance or D-HADH activity in the small intestine, liver or muscle. It might be that regulation of this gene and its enzyme activity does not occur at the substrate level.
The gene expression data did not necessarily parallel the enzyme activity profiles. Besides the possibility that protein activity does not reflect transcript abundance in the cell, one explanation is that total RNA was extracted from the entire tissue sample, whereas enzymatic activity was assayed in specific cellular fractions (e.g., L-HAOX in peroxisomes and D-AAOX and D-HADH in mitochondria), with normalized quantities calculated by different methods.
There was an overall lack of treatment effects on enzyme activities. This may be due to an excess of enzyme, with activity thus not being inducible by an increase in substrate. Fang et al. (2010) examined the activities of the three oxidases in piglets supplemented with DL-Met and DL-HMTBA. They observed increased D-HADH activity in the stomach after DL-HMTBA supplementation compared to DL-Met and increased D-AAOX activity in the kidney and duodenum after DL-Met supplementation compared to DL-HMTBA. No dietary treatment effects were observed in the liver, muscle, and other segments of the intestine, which is similar to our chicken results.
The site of absorption in the small intestine of DL-Met and DL-HMTBA may affect the expression of the converting enzymes in different intestinal segments. DL-Met is mainly absorbed in the small intestine through carrier-mediated transport (SorianoGarcia et al., 1998) . As an organic acid, DL-HMTBA is taken up slowly in the small intestine and stays at a higher concentration in the jejunum and ileum (Maenz and Engele-Schaan, 1996) . DL-HMTBA is absorbed through active monocarboxylic acid transportermediated uptake (Maenz and Engele-Schaan, 1996) .
In summary, dietary Met supplementation affected transcript abundance and activity of Met oxidases. The three Met oxidases were present in the small intestine, liver and muscle and showed tissue-and development-specific expression and activity profiles. The liver showed greater mRNA abundance of the D-and L-HMTBA oxidases, while breast muscle and liver expressed more DAO mRNA than other tissues.
Enzyme activity data for D-AAOX, L-HAOX, and D-HADH provide the first evidence that there might be limitations in conversion of D-HMTBA because of low D-HADH activity compared to L-HAOX and D-AAOX. Moreover, liver and duodenum play a major role in L-HMTBA conversion, while liver, muscle, and duodenum are similarly involved in D-Met conversion. These results provide insights into the mechanisms underlying differences in bioavailability of different sources of supplemental Met and suggest that the transcriptional and post-translational regulation of Met oxidases may be a determining factor in the relative bioefficacy of the different forms of Met.
